The largest database of trusted experimental protocols

Alzet mini osmotic pumps model 1002

Manufactured by Durect
Sourced in United States

Alzet mini-osmotic pumps (model 1002) are laboratory equipment designed to provide continuous and controlled delivery of substances. These pumps operate using an osmotic mechanism, allowing for a predictable and steady release of the contained substance over an extended period.

Automatically generated - may contain errors

2 protocols using alzet mini osmotic pumps model 1002

1

Chronic TGF-β2 Infusion in Diabetic Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 1 week of acclimatization, two mice were placed into each cage, to avoid social isolation, and cage-mates were not changed during the experiment. Chronic TGF-β2 infusion was performed as previously described (Takahashi et al., 2019 (link)). Briefly, the animals were randomly allocated to three groups at 10 weeks of age: WT + vehicle; db/db + vehicle, and db/db + TGF-β2 groups. Under isoflurane anesthesia (induction: 4%, maintenance: 2%), the mice underwent surgery to implant Alzet mini-osmotic pumps (model 1002, Durect, Cupertino, CA, United States) subcutaneously. The osmotic pumps were filled with recombinant TGF-β2 (8406LC, Cell Signaling Technologies, Danvers, MA, United States) diluted in PBS, or PBS alone for the WT + vehicle and db/db + vehicle groups. For 12 consecutive days, the mice received 12 ng TGF-β2 each per hour. After euthanasia, the pumps were removed and the contents were confirmed to have been completely discharged. The dose and duration of treatment were those used in a previous study (Takahashi et al., 2019 (link)).
+ Open protocol
+ Expand
2

AngII-Induced Hypertension Model in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male 8 to 10-week-old male C57/B6 mice were purchased from the Shanghai Experimental Animal Center, China. The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the United States National Institutes of Health (NIH Publication No. 85-23, revised 1996) and was approved by the Ethics Review Board of Ruijin Hospital, Shanghai, China. Four groups of animals were included: vehicle infusion (0.9% NaCl solution, control), vehicle infusion+EMD638683, AngII infusion, Ang II infusion+EMD638683. Ang II (1000 ng/kg/min) was infused for 2 weeks using Alzet mini-osmotic pumps (model 1002, DURECT, Cupertino, CA, United States) implanted subcutaneously in the surgery. EMD638383 was delivered i.p daily at a dosage of 10 mg/kg body weight. Systolic blood pressure was measured on every week by tail-cuff plethysmography (Visitech Systems, Apex, NC, United States) as a control for efficient AngII infusion. All surgical procedures were practiced under anesthesia.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!